| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Patrick Kristin serves as a Director at SLE and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 1 sell.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | NAGE Niagen Bioscience, Inc. | Director | Sale+OE | 23,000 | $3.57 | $82,110.00 | - | +117.4% | +184.3% |